Respana Therapeutics
UEI: QGKNUK6SJUW4
• CAGE: 7TUT8
Overview
Awardee Type
Parent
Name
Respana Therapeutics
Headquarters
Philadelphia, PA
United States
United States
Most Recent Award
June 20, 2022
Calculating
Federal grant recipient
RESPANA THERAPEUTICS, INC
(UEI QGKNUK6SJUW4, CAGE 7TUT8)
is headquartered in Philadelphia PA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2017 and
federally registered in
March 2017.
Federal Award Analysis
Respana Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
RESPANA THERAPEUTICS, INC
UEI
QGKNUK6SJUW4
CAGE Code
7TUT8
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 7, 2017
Initial Registration
March 17, 2017
Last Registration
Feb. 19, 2025
Registration Activation
Feb. 19, 2025
Registration Expiration
Feb. 17, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Accepts Credit Cards
No